bi 187004 cl
Small moleculeexperimental
Clinical trial activity
7 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
6
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2012 (NCT01587417)
Timeline
Indications
Mechanism of action
HSD11B2 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- bi 187004 cl
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02305901 | Phase 1 | Dec 1, 2014 | Boehringer Ingelheim |
| NCT02254148 | Phase 1 | Oct 1, 2014 | Boehringer Ingelheim |
| NCT02150824 | Phase 2 | Jul 1, 2014 | Boehringer Ingelheim |
| NCT02161432 | Phase 1 | Jun 1, 2014 | Boehringer Ingelheim |
| NCT02109679 | Phase 1 | May 1, 2014 | Boehringer Ingelheim |
| NCT01874483 | Phase 1 | Jun 1, 2013 | Boehringer Ingelheim |
| NCT01587417 | Phase 1 | Apr 1, 2012 | Boehringer Ingelheim |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Boehringer Ingelheim | For profit | 7 | 7 | 2 | 2012 |
1 organizations
Page 1 / 1